|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Genetic polymorphisms of the CYP3A4,CYP3A5,and MDR21 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus显示文摘 | Hesselink DA van Schaik RH van der Heiden IP | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 2 | Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus显示文摘 | Hesselink DA van Schaik RH van der Heiden | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 3 | The role of coping resources and coping style in quality of life of patients with asthma or COPD显示文摘 | Hesselink AE Penninx BW Schlosser MA Wijnhoven HA van der Windt DA Kriegsman DM van Eijk JT | 2004 | Qual Life Res2004，13，2： | 1 |
| 4 | High-risk Human papillomavirus DNA load in a population-based cervical screening co- hort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical eancer显示文摘 | Hesselink AT Berkhor J Heideman DA | 2009 | Int J Cancer2009，124，： | 1 |
| 5 | A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients显示文摘 | Elens L Bouamar R Hesselink DA | 2011 | Clin Chem2011，57，11： | 1 |
| 6 | High - risk human papillomavirus DNA load in a population - based cervical screening cohort in relation to the detection of high - grade cervical intraepithelial neoplasia and cervical cancer 显示文摘 | Hesselink AT Berkhof J Heideman DA | 2009 | Int J Cancer2009，124，： | 1 |
| 7 | Combined promoter methylation analysis of CADM1 and MAL:an objective triage tool for high-risk human papillomavirus DNA-positive women 显示文摘 | Hesselink AT Heideman DA Steenbergen RD | 2011 | Clin Cancer Res2011，17，8： | 1 |
| 8 | Genetic polymorphisms of the CYP3A4, CYP3AS, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus 显示文摘 | Hesselink DA van Schaik RH van der Heiden IP | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 9 | Protection against renal ischemia-reperfusion injury by ischemic postconditioning显示文摘 | van den Akker EK Manintveld OC Hesselink DA | 2013 | Transplantation2013，95，11： | 1 |
| 10 | High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer 显示文摘 | Hesselink AT Berkhof J Heideman DA | 2009 | lnt JCaneer2009，124，2： | 1 |
| 11 | Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmaeokinetics of the ealeineurin inhibitors eyclosporine and tacrolimus显示文摘 | Hesselink DA van Schaik RH van der Heiden IP | 2003 | Clin Pharrnacol Ther2003，74，3： | 1 |
| 12 | Genetic polymorphisms of the CYP3A4, CYP3AS, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacroli- mus显示文摘 | Hesselink DA van Schaik RH van der Heiden IP | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 13 | Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus显示文摘 | Hesselink DA Aarden LA Swaak AJ | 2003 | Scand J Rheumatol2003，32，3： | 1 |
| 14 | What predicts change in pulmonary function and quality of life in asthma or COPD? 显示文摘 | Hesselink AE van der Windt DA Penninx BW | 2006 | J Asthma2006，43，7： | 1 |
| 15 | Genetic polymorphisms of the CYP3A4,CYP3A5,and MDR2 1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus显示文摘 | Hesselink DA van Schaik RH van der Heiden IP | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 16 | Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and phar- macokinetics of the calcineurin inhibitors cyclosporine and tacrolimus 显示文摘 | Hesselink DA van Schaik RHN van der Heiden IP | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 17 | The use of Cyclosporine in renal transplantation显示文摘 | Hesselink DA Smark Gregoor PJ Weimar W | 2004 | Transplant Proc2004，36，2： | 1 |
| 18 | The use of Cyclosporine in renal transplantation显示文摘 | Hesselink DA Gregoor PJ Smark H | 2004 | Transplant Proc2004，36，2： | 1 |
| 19 | Genetic polymorphisms of the CYP3A4, CYP3AS, and MDR-1 genes and pharmacokinetics of the calcineur ininhibitors cyclospofine and tacrolimus 显示文摘 | Hesselink DA van Sehaik RH van derHeiden IP | 2003 | Clin Pharmacol Ther2003，74，3： | 1 |
| 20 | Combin- ed promoter methylation analysis of CADM1 and MAL: an ob- jective triage tool for high-risk human papillomavirus DNA-posi- tire women 显示文摘 | Hesselink AT Heideman DA Steenbergen RD | 2011 | Clin Cancer Res2011，17，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员